nodes	percent_of_prediction	percent_of_DWPC	metapath
Niacin—HCAR3—endocrine gland—polycystic ovary syndrome	0.0243	0.0769	CbGeAlD
Niacin—HCAR2—adipose tissue—polycystic ovary syndrome	0.0207	0.0655	CbGeAlD
Niacin—QPRT—endocrine gland—polycystic ovary syndrome	0.0192	0.0608	CbGeAlD
Niacin—HCAR2—endocrine gland—polycystic ovary syndrome	0.0161	0.0509	CbGeAlD
Niacin—Salicylic acid—AKR1C1—polycystic ovary syndrome	0.015	1	CrCbGaD
Niacin—NNMT—adrenal cortex—polycystic ovary syndrome	0.0144	0.0458	CbGeAlD
Niacin—NNMT—endometrium—polycystic ovary syndrome	0.0129	0.0409	CbGeAlD
Niacin—NNMT—uterus—polycystic ovary syndrome	0.0119	0.0377	CbGeAlD
Niacin—NNMT—pituitary gland—polycystic ovary syndrome	0.0117	0.037	CbGeAlD
Niacin—NNMT—adipose tissue—polycystic ovary syndrome	0.0116	0.0368	CbGeAlD
Niacin—NNMT—adrenal gland—polycystic ovary syndrome	0.0104	0.033	CbGeAlD
Niacin—NNMT—female gonad—polycystic ovary syndrome	0.00972	0.0308	CbGeAlD
Niacin—NNMT—vagina—polycystic ovary syndrome	0.00966	0.0306	CbGeAlD
Niacin—NNMT—endocrine gland—polycystic ovary syndrome	0.00904	0.0287	CbGeAlD
Niacin—SLC16A3—endometrium—polycystic ovary syndrome	0.00881	0.0279	CbGeAlD
Niacin—CYP2D6—urine—polycystic ovary syndrome	0.00834	0.0264	CbGeAlD
Niacin—SLC16A3—uterus—polycystic ovary syndrome	0.00812	0.0257	CbGeAlD
Niacin—SLC16A3—pituitary gland—polycystic ovary syndrome	0.00797	0.0253	CbGeAlD
Niacin—SLC16A3—adipose tissue—polycystic ovary syndrome	0.00794	0.0252	CbGeAlD
Niacin—SLC16A3—adrenal gland—polycystic ovary syndrome	0.00712	0.0226	CbGeAlD
Niacin—SLC16A3—female gonad—polycystic ovary syndrome	0.00664	0.021	CbGeAlD
Niacin—Gastrointestinal symptom NOS—Metformin—polycystic ovary syndrome	0.0065	0.079	CcSEcCtD
Niacin—SLC16A3—endocrine gland—polycystic ovary syndrome	0.00617	0.0196	CbGeAlD
Niacin—Heartburn—Metformin—polycystic ovary syndrome	0.00556	0.0675	CcSEcCtD
Niacin—SLC16A1—endometrium—polycystic ovary syndrome	0.00535	0.017	CbGeAlD
Niacin—SLC16A1—uterus—polycystic ovary syndrome	0.00493	0.0156	CbGeAlD
Niacin—SLC16A1—pituitary gland—polycystic ovary syndrome	0.00484	0.0153	CbGeAlD
Niacin—SLC16A1—adipose tissue—polycystic ovary syndrome	0.00482	0.0153	CbGeAlD
Niacin—SLC16A1—adrenal gland—polycystic ovary syndrome	0.00432	0.0137	CbGeAlD
Niacin—SLCO2B1—uterus—polycystic ovary syndrome	0.00424	0.0134	CbGeAlD
Niacin—SLCO2B1—adipose tissue—polycystic ovary syndrome	0.00415	0.0132	CbGeAlD
Niacin—SLC16A1—female gonad—polycystic ovary syndrome	0.00403	0.0128	CbGeAlD
Niacin—SLC16A1—endocrine gland—polycystic ovary syndrome	0.00375	0.0119	CbGeAlD
Niacin—SLCO2B1—adrenal gland—polycystic ovary syndrome	0.00372	0.0118	CbGeAlD
Niacin—SLCO2B1—female gonad—polycystic ovary syndrome	0.00347	0.011	CbGeAlD
Niacin—SLC22A5—adrenal cortex—polycystic ovary syndrome	0.00342	0.0109	CbGeAlD
Niacin—SLCO2B1—endocrine gland—polycystic ovary syndrome	0.00323	0.0102	CbGeAlD
Niacin—SLC22A5—endometrium—polycystic ovary syndrome	0.00306	0.00969	CbGeAlD
Niacin—SLC22A5—pituitary gland—polycystic ovary syndrome	0.00277	0.00877	CbGeAlD
Niacin—SLC22A5—adipose tissue—polycystic ovary syndrome	0.00275	0.00873	CbGeAlD
Niacin—Migraine—Metformin—polycystic ovary syndrome	0.00273	0.0332	CcSEcCtD
Niacin—Liver function test abnormal—Metformin—polycystic ovary syndrome	0.00256	0.0311	CcSEcCtD
Niacin—SLC22A5—adrenal gland—polycystic ovary syndrome	0.00247	0.00783	CbGeAlD
Niacin—Abdominal distension—Metformin—polycystic ovary syndrome	0.00242	0.0293	CcSEcCtD
Niacin—Influenza—Metformin—polycystic ovary syndrome	0.0024	0.0291	CcSEcCtD
Niacin—Angina pectoris—Metformin—polycystic ovary syndrome	0.00234	0.0284	CcSEcCtD
Niacin—SLC22A5—female gonad—polycystic ovary syndrome	0.0023	0.00731	CbGeAlD
Niacin—SLC22A5—vagina—polycystic ovary syndrome	0.00229	0.00726	CbGeAlD
Niacin—Rhinitis—Metformin—polycystic ovary syndrome	0.00193	0.0234	CcSEcCtD
Niacin—Hepatitis—Metformin—polycystic ovary syndrome	0.00192	0.0233	CcSEcCtD
Niacin—Hypoaesthesia—Metformin—polycystic ovary syndrome	0.00191	0.0232	CcSEcCtD
Niacin—Oedema peripheral—Metformin—polycystic ovary syndrome	0.00189	0.023	CcSEcCtD
Niacin—Eye disorder—Metformin—polycystic ovary syndrome	0.00179	0.0218	CcSEcCtD
Niacin—Flushing—Metformin—polycystic ovary syndrome	0.00178	0.0216	CcSEcCtD
Niacin—Angiopathy—Metformin—polycystic ovary syndrome	0.00174	0.0212	CcSEcCtD
Niacin—Chills—Metformin—polycystic ovary syndrome	0.00172	0.0209	CcSEcCtD
Niacin—Malnutrition—Metformin—polycystic ovary syndrome	0.00167	0.0203	CcSEcCtD
Niacin—Erythema—Metformin—polycystic ovary syndrome	0.00167	0.0203	CcSEcCtD
Niacin—Flatulence—Metformin—polycystic ovary syndrome	0.00165	0.02	CcSEcCtD
Niacin—Muscle spasms—Metformin—polycystic ovary syndrome	0.00161	0.0195	CcSEcCtD
Niacin—Vision blurred—Metformin—polycystic ovary syndrome	0.00158	0.0191	CcSEcCtD
Niacin—Syncope—Metformin—polycystic ovary syndrome	0.0015	0.0182	CcSEcCtD
Niacin—CYP2D6—female gonad—polycystic ovary syndrome	0.00149	0.00471	CbGeAlD
Niacin—Palpitations—Metformin—polycystic ovary syndrome	0.00148	0.0179	CcSEcCtD
Niacin—Loss of consciousness—Metformin—polycystic ovary syndrome	0.00147	0.0178	CcSEcCtD
Niacin—Myalgia—Metformin—polycystic ovary syndrome	0.00142	0.0173	CcSEcCtD
Niacin—Unspecified disorder of skin and subcutaneous tissue—Metformin—polycystic ovary syndrome	0.00141	0.0172	CcSEcCtD
Niacin—CYP2D6—endocrine gland—polycystic ovary syndrome	0.00138	0.00438	CbGeAlD
Niacin—Oedema—Metformin—polycystic ovary syndrome	0.00136	0.0166	CcSEcCtD
Niacin—Shock—Metformin—polycystic ovary syndrome	0.00134	0.0163	CcSEcCtD
Niacin—Skin disorder—Metformin—polycystic ovary syndrome	0.00133	0.0161	CcSEcCtD
Niacin—Hyperhidrosis—Metformin—polycystic ovary syndrome	0.00132	0.016	CcSEcCtD
Niacin—Anorexia—Metformin—polycystic ovary syndrome	0.0013	0.0158	CcSEcCtD
Niacin—Hypotension—Metformin—polycystic ovary syndrome	0.00127	0.0155	CcSEcCtD
Niacin—Musculoskeletal discomfort—Metformin—polycystic ovary syndrome	0.00124	0.0151	CcSEcCtD
Niacin—Paraesthesia—Metformin—polycystic ovary syndrome	0.00123	0.0149	CcSEcCtD
Niacin—Dyspnoea—Metformin—polycystic ovary syndrome	0.00122	0.0148	CcSEcCtD
Niacin—Somnolence—Metformin—polycystic ovary syndrome	0.00121	0.0147	CcSEcCtD
Niacin—Dyspepsia—Metformin—polycystic ovary syndrome	0.0012	0.0146	CcSEcCtD
Niacin—Decreased appetite—Metformin—polycystic ovary syndrome	0.00119	0.0144	CcSEcCtD
Niacin—Gastrointestinal disorder—Metformin—polycystic ovary syndrome	0.00118	0.0143	CcSEcCtD
Niacin—Gastrointestinal pain—Metformin—polycystic ovary syndrome	0.00112	0.0135	CcSEcCtD
Niacin—Urticaria—Metformin—polycystic ovary syndrome	0.00108	0.0132	CcSEcCtD
Niacin—Abdominal pain—Metformin—polycystic ovary syndrome	0.00108	0.0131	CcSEcCtD
Niacin—Asthenia—Metformin—polycystic ovary syndrome	0.000979	0.0119	CcSEcCtD
Niacin—Pruritus—Metformin—polycystic ovary syndrome	0.000965	0.0117	CcSEcCtD
Niacin—Diarrhoea—Metformin—polycystic ovary syndrome	0.000934	0.0113	CcSEcCtD
Niacin—Dizziness—Metformin—polycystic ovary syndrome	0.000902	0.011	CcSEcCtD
Niacin—Vomiting—Metformin—polycystic ovary syndrome	0.000868	0.0105	CcSEcCtD
Niacin—Rash—Metformin—polycystic ovary syndrome	0.00086	0.0104	CcSEcCtD
Niacin—Dermatitis—Metformin—polycystic ovary syndrome	0.00086	0.0104	CcSEcCtD
Niacin—Headache—Metformin—polycystic ovary syndrome	0.000855	0.0104	CcSEcCtD
Niacin—Nausea—Metformin—polycystic ovary syndrome	0.00081	0.00984	CcSEcCtD
Niacin—HCAR2—Signaling Pathways—SCT—polycystic ovary syndrome	0.000438	0.000747	CbGpPWpGaD
Niacin—NNMT—Metabolism—AKR1C3—polycystic ovary syndrome	0.000434	0.000739	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—GNRH1—polycystic ovary syndrome	0.000434	0.000738	CbGpPWpGaD
Niacin—HCAR2—Signaling by GPCR—ADRB2—polycystic ovary syndrome	0.000433	0.000737	CbGpPWpGaD
Niacin—CYP2D6—Metapathway biotransformation—AKR1C2—polycystic ovary syndrome	0.000429	0.000731	CbGpPWpGaD
Niacin—NNMT—Metabolism—CYP17A1—polycystic ovary syndrome	0.000427	0.000727	CbGpPWpGaD
Niacin—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP17A1—polycystic ovary syndrome	0.000426	0.000725	CbGpPWpGaD
Niacin—CYP2D6—Oxidation by Cytochrome P450—CYP17A1—polycystic ovary syndrome	0.00042	0.000716	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—AKR1C1—polycystic ovary syndrome	0.00042	0.000715	CbGpPWpGaD
Niacin—HCAR3—GPCR downstream signaling—GNAS—polycystic ovary syndrome	0.000419	0.000714	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—RACGAP1—polycystic ovary syndrome	0.000418	0.000712	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—MTNR1B—polycystic ovary syndrome	0.000418	0.000712	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—SCT—polycystic ovary syndrome	0.000416	0.000708	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—PNPLA2—polycystic ovary syndrome	0.000414	0.000706	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—FGF18—polycystic ovary syndrome	0.000411	0.0007	CbGpPWpGaD
Niacin—HCAR3—Signaling by GPCR—ADRB2—polycystic ovary syndrome	0.00041	0.000699	CbGpPWpGaD
Niacin—SLC16A3—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	0.00041	0.000698	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—RBP4—polycystic ovary syndrome	0.000408	0.000694	CbGpPWpGaD
Niacin—HCAR2—Signaling by GPCR—GNAS—polycystic ovary syndrome	0.000401	0.000684	CbGpPWpGaD
Niacin—SLC16A1—SLC-mediated transmembrane transport—SLC2A4—polycystic ovary syndrome	0.000398	0.000678	CbGpPWpGaD
Niacin—QPRT—Metabolism—TH—polycystic ovary syndrome	0.000397	0.000677	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—MTNR1B—polycystic ovary syndrome	0.000397	0.000675	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—SRD5A1—polycystic ovary syndrome	0.000393	0.000669	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—FGF18—polycystic ovary syndrome	0.00039	0.000664	CbGpPWpGaD
Niacin—QPRT—Metabolism—SLC2A4—polycystic ovary syndrome	0.000387	0.000658	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—RBP4—polycystic ovary syndrome	0.000386	0.000658	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—YAP1—polycystic ovary syndrome	0.000381	0.000648	CbGpPWpGaD
Niacin—HCAR3—Signaling by GPCR—GNAS—polycystic ovary syndrome	0.00038	0.000648	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—GAB1—polycystic ovary syndrome	0.000375	0.000639	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—STAR—polycystic ovary syndrome	0.000375	0.000638	CbGpPWpGaD
Niacin—SLC16A3—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	0.000375	0.000638	CbGpPWpGaD
Niacin—CYP2D6—Phase 1 - Functionalization of compounds—CYP11A1—polycystic ovary syndrome	0.000371	0.000632	CbGpPWpGaD
Niacin—NNMT—Metabolism—TH—polycystic ovary syndrome	0.000369	0.000629	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—NMNAT3—polycystic ovary syndrome	0.000369	0.000629	CbGpPWpGaD
Niacin—QPRT—Disease—NCOR1—polycystic ovary syndrome	0.000369	0.000628	CbGpPWpGaD
Niacin—QPRT—Metabolism—CYP19A1—polycystic ovary syndrome	0.000363	0.000619	CbGpPWpGaD
Niacin—SLC16A3—Hemostasis—GNAS—polycystic ovary syndrome	0.000363	0.000619	CbGpPWpGaD
Niacin—QPRT—Disease—NRG1—polycystic ovary syndrome	0.000362	0.000617	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—YAP1—polycystic ovary syndrome	0.000361	0.000614	CbGpPWpGaD
Niacin—NNMT—Metabolism—SLC2A4—polycystic ovary syndrome	0.000359	0.000612	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—INSR—polycystic ovary syndrome	0.000359	0.000611	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—GAB1—polycystic ovary syndrome	0.000356	0.000606	CbGpPWpGaD
Niacin—CYP2D6—Phase 1 - Functionalization of compounds—CYP17A1—polycystic ovary syndrome	0.000345	0.000588	CbGpPWpGaD
Niacin—SLC22A5—SLC-mediated transmembrane transport—SLC2A4—polycystic ovary syndrome	0.000342	0.000583	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—AKR1C3—polycystic ovary syndrome	0.000341	0.000581	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—INSR—polycystic ovary syndrome	0.00034	0.000579	CbGpPWpGaD
Niacin—NNMT—Metabolism—CYP19A1—polycystic ovary syndrome	0.000338	0.000575	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—SUOX—polycystic ovary syndrome	0.000338	0.000575	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—LPCAT2—polycystic ovary syndrome	0.000338	0.000575	CbGpPWpGaD
Niacin—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP19A1—polycystic ovary syndrome	0.000337	0.000574	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—TNRC6B—polycystic ovary syndrome	0.000336	0.000572	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—HMMR—polycystic ovary syndrome	0.000334	0.000569	CbGpPWpGaD
Niacin—CYP2D6—Oxidation by Cytochrome P450—CYP19A1—polycystic ovary syndrome	0.000333	0.000566	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—PGR—polycystic ovary syndrome	0.000332	0.000566	CbGpPWpGaD
Niacin—QPRT—Disease—MTHFR—polycystic ovary syndrome	0.000326	0.000555	CbGpPWpGaD
Niacin—QPRT—Metabolism—GNAS—polycystic ovary syndrome	0.000324	0.000552	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—AKR1C3—polycystic ovary syndrome	0.000323	0.00055	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—HSD3B1—polycystic ovary syndrome	0.000319	0.000543	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—TNRC6B—polycystic ovary syndrome	0.000318	0.000542	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—PGR—polycystic ovary syndrome	0.000315	0.000536	CbGpPWpGaD
Niacin—SLC16A3—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	0.000314	0.000536	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—ISYNA1—polycystic ovary syndrome	0.000314	0.000535	CbGpPWpGaD
Niacin—QPRT—Disease—IRS2—polycystic ovary syndrome	0.00031	0.000528	CbGpPWpGaD
Niacin—QPRT—Metabolism—NCOR1—polycystic ovary syndrome	0.000309	0.000526	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—PLAT—polycystic ovary syndrome	0.000309	0.000526	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—GHRL—polycystic ovary syndrome	0.000309	0.000526	CbGpPWpGaD
Niacin—NNMT—Metabolism—GNAS—polycystic ovary syndrome	0.000302	0.000514	CbGpPWpGaD
Niacin—HCAR2—GPCR downstream signaling—POMC—polycystic ovary syndrome	0.000298	0.000507	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—ATF1—polycystic ovary syndrome	0.000295	0.000502	CbGpPWpGaD
Niacin—QPRT—Metabolism—CYP1A1—polycystic ovary syndrome	0.000293	0.000499	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—PLAT—polycystic ovary syndrome	0.000293	0.000499	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—GHRL—polycystic ovary syndrome	0.000293	0.000499	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—LHB—polycystic ovary syndrome	0.000291	0.000495	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—TCF7L2—polycystic ovary syndrome	0.000287	0.000489	CbGpPWpGaD
Niacin—NNMT—Metabolism—NCOR1—polycystic ovary syndrome	0.000287	0.000489	CbGpPWpGaD
Niacin—HCAR2—GPCR downstream signaling—AKT2—polycystic ovary syndrome	0.000286	0.000487	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—HSD3B2—polycystic ovary syndrome	0.000284	0.000484	CbGpPWpGaD
Niacin—HCAR3—GPCR downstream signaling—POMC—polycystic ovary syndrome	0.000282	0.00048	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—ATF1—polycystic ovary syndrome	0.000279	0.000476	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—AKR1C1—polycystic ovary syndrome	0.000275	0.000469	CbGpPWpGaD
Niacin—CYP2D6—Phase 1 - Functionalization of compounds—CYP19A1—polycystic ovary syndrome	0.000273	0.000465	CbGpPWpGaD
Niacin—QPRT—Metabolism—MTHFR—polycystic ovary syndrome	0.000273	0.000465	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—TCF7L2—polycystic ovary syndrome	0.000272	0.000464	CbGpPWpGaD
Niacin—NNMT—Metabolism—CYP1A1—polycystic ovary syndrome	0.000272	0.000464	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—NGFR—polycystic ovary syndrome	0.000272	0.000463	CbGpPWpGaD
Niacin—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP1A1—polycystic ovary syndrome	0.000272	0.000463	CbGpPWpGaD
Niacin—HCAR3—GPCR downstream signaling—AKT2—polycystic ovary syndrome	0.000271	0.000462	CbGpPWpGaD
Niacin—QPRT—Disease—IRS1—polycystic ovary syndrome	0.000271	0.000461	CbGpPWpGaD
Niacin—HCAR2—Signaling by GPCR—POMC—polycystic ovary syndrome	0.00027	0.00046	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—PRL—polycystic ovary syndrome	0.00027	0.000459	CbGpPWpGaD
Niacin—CYP2D6—Oxidation by Cytochrome P450—CYP1A1—polycystic ovary syndrome	0.000268	0.000457	CbGpPWpGaD
Niacin—SLCO2B1—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	0.000268	0.000456	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—AKR1C2—polycystic ovary syndrome	0.000267	0.000455	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—TEAD2—polycystic ovary syndrome	0.000267	0.000455	CbGpPWpGaD
Niacin—HCAR2—Signaling by GPCR—AKT2—polycystic ovary syndrome	0.00026	0.000442	CbGpPWpGaD
Niacin—QPRT—Disease—INS—polycystic ovary syndrome	0.000259	0.000442	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—NGFR—polycystic ovary syndrome	0.000258	0.000439	CbGpPWpGaD
Niacin—HCAR3—Signaling by GPCR—POMC—polycystic ovary syndrome	0.000256	0.000436	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—ADRB2—polycystic ovary syndrome	0.000256	0.000435	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—PLAT—polycystic ovary syndrome	0.000256	0.000435	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—PRL—polycystic ovary syndrome	0.000256	0.000435	CbGpPWpGaD
Niacin—NNMT—Metabolism—MTHFR—polycystic ovary syndrome	0.000254	0.000432	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—SULT2A1—polycystic ovary syndrome	0.000253	0.000431	CbGpPWpGaD
Niacin—QPRT—Disease—AKT2—polycystic ovary syndrome	0.000251	0.000427	CbGpPWpGaD
Niacin—SLCO2B1—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	0.000249	0.000424	CbGpPWpGaD
Niacin—HCAR3—Signaling by GPCR—AKT2—polycystic ovary syndrome	0.000246	0.000419	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—RRM2—polycystic ovary syndrome	0.000245	0.000418	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—ADRB2—polycystic ovary syndrome	0.000242	0.000413	CbGpPWpGaD
Niacin—CYP2D6—Metapathway biotransformation—AKR1C1—polycystic ovary syndrome	0.000239	0.000406	CbGpPWpGaD
Niacin—QPRT—Disease—SERPINE1—polycystic ovary syndrome	0.000238	0.000406	CbGpPWpGaD
Niacin—SLC16A1—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	0.000238	0.000405	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—GNAS—polycystic ovary syndrome	0.000237	0.000404	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—YAP1—polycystic ovary syndrome	0.000236	0.000403	CbGpPWpGaD
Niacin—SLC16A3—Hemostasis—IGF1—polycystic ovary syndrome	0.000235	0.000401	CbGpPWpGaD
Niacin—SLC16A3—Hemostasis—AKT2—polycystic ovary syndrome	0.000235	0.0004	CbGpPWpGaD
Niacin—SLCO2B1—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	0.000228	0.000388	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—NAMPT—polycystic ovary syndrome	0.000227	0.000387	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—NCOR1—polycystic ovary syndrome	0.000226	0.000385	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—GNAS—polycystic ovary syndrome	0.000225	0.000383	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—CYP11A1—polycystic ovary syndrome	0.000224	0.000382	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—PNPLA2—polycystic ovary syndrome	0.000224	0.000381	CbGpPWpGaD
Niacin—SLC16A3—Hemostasis—SERPINE1—polycystic ovary syndrome	0.000223	0.00038	CbGpPWpGaD
Niacin—CYP2D6—Biological oxidations—SULT2A1—polycystic ovary syndrome	0.000223	0.000379	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—NRG1—polycystic ovary syndrome	0.000222	0.000378	CbGpPWpGaD
Niacin—QPRT—Metabolism—PPARG—polycystic ovary syndrome	0.000221	0.000377	CbGpPWpGaD
Niacin—SLC16A1—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	0.000221	0.000377	CbGpPWpGaD
Niacin—CYP2D6—Phase 1 - Functionalization of compounds—CYP1A1—polycystic ovary syndrome	0.00022	0.000375	CbGpPWpGaD
Niacin—CYP2D6—Metapathway biotransformation—SULT2A1—polycystic ovary syndrome	0.00022	0.000374	CbGpPWpGaD
Niacin—QPRT—Metabolism—POMC—polycystic ovary syndrome	0.000218	0.000372	CbGpPWpGaD
Niacin—QPRT—Metabolism—INS—polycystic ovary syndrome	0.000217	0.00037	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—NCOR1—polycystic ovary syndrome	0.000214	0.000365	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—SRD5A1—polycystic ovary syndrome	0.000212	0.000361	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—AKR1C3—polycystic ovary syndrome	0.000212	0.000361	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—NRG1—polycystic ovary syndrome	0.00021	0.000358	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—CYP17A1—polycystic ovary syndrome	0.000209	0.000355	CbGpPWpGaD
Niacin—NNMT—Metabolism—PPARG—polycystic ovary syndrome	0.000206	0.000351	CbGpPWpGaD
Niacin—SLC22A5—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	0.000205	0.000348	CbGpPWpGaD
Niacin—NNMT—Metabolism—POMC—polycystic ovary syndrome	0.000203	0.000346	CbGpPWpGaD
Niacin—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—polycystic ovary syndrome	0.000203	0.000345	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—STAR—polycystic ovary syndrome	0.000202	0.000345	CbGpPWpGaD
Niacin—SLC16A1—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	0.000202	0.000345	CbGpPWpGaD
Niacin—NNMT—Metabolism—INS—polycystic ovary syndrome	0.000202	0.000344	CbGpPWpGaD
Niacin—CYP2D6—Biological oxidations—CYP11A1—polycystic ovary syndrome	0.000197	0.000336	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—GNAS—polycystic ovary syndrome	0.000196	0.000334	CbGpPWpGaD
Niacin—CYP2D6—Metapathway biotransformation—CYP11A1—polycystic ovary syndrome	0.000195	0.000331	CbGpPWpGaD
Niacin—SLCO2B1—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	0.000191	0.000325	CbGpPWpGaD
Niacin—SLC22A5—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	0.00019	0.000324	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—IRS2—polycystic ovary syndrome	0.00019	0.000323	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—LEP—polycystic ovary syndrome	0.000186	0.000316	CbGpPWpGaD
Niacin—CYP2D6—Metapathway biotransformation—AKR1C3—polycystic ovary syndrome	0.000184	0.000313	CbGpPWpGaD
Niacin—CYP2D6—Biological oxidations—CYP17A1—polycystic ovary syndrome	0.000183	0.000312	CbGpPWpGaD
Niacin—CYP2D6—Metapathway biotransformation—CYP17A1—polycystic ovary syndrome	0.000181	0.000308	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—HMMR—polycystic ovary syndrome	0.00018	0.000307	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—TH—polycystic ovary syndrome	0.00018	0.000307	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—IRS2—polycystic ovary syndrome	0.00018	0.000307	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—LEP—polycystic ovary syndrome	0.000176	0.0003	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—SLC2A4—polycystic ovary syndrome	0.000176	0.000299	CbGpPWpGaD
Niacin—SLC22A5—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	0.000174	0.000296	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—HSD3B1—polycystic ovary syndrome	0.000172	0.000293	CbGpPWpGaD
Niacin—SLC16A1—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	0.00017	0.000289	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—IRS1—polycystic ovary syndrome	0.000166	0.000282	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—CYP19A1—polycystic ovary syndrome	0.000165	0.000281	CbGpPWpGaD
Niacin—CYP2D6—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	0.000164	0.00028	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—POMC—polycystic ovary syndrome	0.00016	0.000272	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—INS—polycystic ovary syndrome	0.000159	0.00027	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—IRS1—polycystic ovary syndrome	0.000157	0.000268	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—LHB—polycystic ovary syndrome	0.000157	0.000267	CbGpPWpGaD
Niacin—SLC16A3—Hemostasis—VEGFA—polycystic ovary syndrome	0.000154	0.000262	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—IGF1—polycystic ovary syndrome	0.000154	0.000262	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—AKT2—polycystic ovary syndrome	0.000153	0.000261	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—HSD3B2—polycystic ovary syndrome	0.000153	0.000261	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—POMC—polycystic ovary syndrome	0.000151	0.000258	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—INS—polycystic ovary syndrome	0.000151	0.000256	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—AKR1C1—polycystic ovary syndrome	0.000149	0.000253	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—GNAS—polycystic ovary syndrome	0.000147	0.000251	CbGpPWpGaD
Niacin—SLC22A5—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	0.000146	0.000249	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—SERPINE1—polycystic ovary syndrome	0.000146	0.000248	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—IGF1—polycystic ovary syndrome	0.000146	0.000248	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—AKT2—polycystic ovary syndrome	0.000145	0.000248	CbGpPWpGaD
Niacin—CYP2D6—Biological oxidations—CYP19A1—polycystic ovary syndrome	0.000145	0.000247	CbGpPWpGaD
Niacin—CYP2D6—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	0.000143	0.000244	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—NCOR1—polycystic ovary syndrome	0.00014	0.000239	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—SERPINE1—polycystic ovary syndrome	0.000138	0.000235	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—SULT2A1—polycystic ovary syndrome	0.000137	0.000233	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—CYP1A1—polycystic ovary syndrome	0.000133	0.000227	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—RRM2—polycystic ovary syndrome	0.000132	0.000226	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—YAP1—polycystic ovary syndrome	0.000128	0.000217	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—IGF1—polycystic ovary syndrome	0.000127	0.000216	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—AKT2—polycystic ovary syndrome	0.000127	0.000216	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—MTHFR—polycystic ovary syndrome	0.000124	0.000211	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—NAMPT—polycystic ovary syndrome	0.000123	0.000209	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—CYP11A1—polycystic ovary syndrome	0.000121	0.000206	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—SERPINE1—polycystic ovary syndrome	0.000121	0.000205	CbGpPWpGaD
Niacin—HCAR2—Signaling by GPCR—IL6—polycystic ovary syndrome	0.000117	0.0002	CbGpPWpGaD
Niacin—CYP2D6—Biological oxidations—CYP1A1—polycystic ovary syndrome	0.000117	0.000199	CbGpPWpGaD
Niacin—CYP2D6—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	0.000115	0.000196	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—AKR1C3—polycystic ovary syndrome	0.000114	0.000195	CbGpPWpGaD
Niacin—QPRT—Disease—IL6—polycystic ovary syndrome	0.000113	0.000193	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—CYP17A1—polycystic ovary syndrome	0.000113	0.000192	CbGpPWpGaD
Niacin—HCAR3—Signaling by GPCR—IL6—polycystic ovary syndrome	0.000111	0.00019	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—NMNAT3—polycystic ovary syndrome	0.000103	0.000175	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—PPARG—polycystic ovary syndrome	0.000101	0.000171	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—VEGFA—polycystic ovary syndrome	0.0001	0.000171	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—POMC—polycystic ovary syndrome	9.92e-05	0.000169	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—INS—polycystic ovary syndrome	9.86e-05	0.000168	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—TH—polycystic ovary syndrome	9.74e-05	0.000166	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—VEGFA—polycystic ovary syndrome	9.51e-05	0.000162	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—SLC2A4—polycystic ovary syndrome	9.48e-05	0.000161	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—LPCAT2—polycystic ovary syndrome	9.41e-05	0.00016	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—SUOX—polycystic ovary syndrome	9.41e-05	0.00016	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—CYP19A1—polycystic ovary syndrome	8.91e-05	0.000152	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—ISYNA1—polycystic ovary syndrome	8.75e-05	0.000149	CbGpPWpGaD
Niacin—CYP2D6—Biological oxidations—POMC—polycystic ovary syndrome	8.72e-05	0.000149	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—VEGFA—polycystic ovary syndrome	8.3e-05	0.000141	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—GNAS—polycystic ovary syndrome	7.95e-05	0.000135	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—NCOR1—polycystic ovary syndrome	7.58e-05	0.000129	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—TEAD2—polycystic ovary syndrome	7.44e-05	0.000127	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—AKR1C2—polycystic ovary syndrome	7.44e-05	0.000127	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—CYP1A1—polycystic ovary syndrome	7.18e-05	0.000122	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—IL6—polycystic ovary syndrome	6.94e-05	0.000118	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—MTHFR—polycystic ovary syndrome	6.7e-05	0.000114	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—IL6—polycystic ovary syndrome	6.58e-05	0.000112	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—PNPLA2—polycystic ovary syndrome	6.23e-05	0.000106	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—SRD5A1—polycystic ovary syndrome	5.91e-05	0.000101	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—STAR—polycystic ovary syndrome	5.64e-05	9.6e-05	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—PPARG—polycystic ovary syndrome	5.43e-05	9.25e-05	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—POMC—polycystic ovary syndrome	5.36e-05	9.12e-05	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—INS—polycystic ovary syndrome	5.33e-05	9.07e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—HMMR—polycystic ovary syndrome	5.03e-05	8.56e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—HSD3B1—polycystic ovary syndrome	4.79e-05	8.16e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—LHB—polycystic ovary syndrome	4.37e-05	7.45e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—HSD3B2—polycystic ovary syndrome	4.27e-05	7.28e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—AKR1C1—polycystic ovary syndrome	4.14e-05	7.05e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—SULT2A1—polycystic ovary syndrome	3.81e-05	6.49e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—RRM2—polycystic ovary syndrome	3.69e-05	6.28e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—YAP1—polycystic ovary syndrome	3.56e-05	6.06e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—NAMPT—polycystic ovary syndrome	3.42e-05	5.82e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—CYP11A1—polycystic ovary syndrome	3.37e-05	5.75e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—AKR1C3—polycystic ovary syndrome	3.19e-05	5.43e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—CYP17A1—polycystic ovary syndrome	3.14e-05	5.34e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—TH—polycystic ovary syndrome	2.71e-05	4.62e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—SLC2A4—polycystic ovary syndrome	2.64e-05	4.5e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—CYP19A1—polycystic ovary syndrome	2.48e-05	4.23e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—GNAS—polycystic ovary syndrome	2.22e-05	3.77e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—NCOR1—polycystic ovary syndrome	2.11e-05	3.59e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—CYP1A1—polycystic ovary syndrome	2e-05	3.41e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—MTHFR—polycystic ovary syndrome	1.87e-05	3.18e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—PPARG—polycystic ovary syndrome	1.51e-05	2.58e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—POMC—polycystic ovary syndrome	1.49e-05	2.54e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—INS—polycystic ovary syndrome	1.48e-05	2.53e-05	CbGpPWpGaD
